APA

Boles J. C., Williams J. C., Hollingsworth R. M., Wang J., Glover S. L., Owens A. P., Barcel D. A., Kasthuri R. S., Key N. S. & Mackman N. (20120522). Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity. : Thrombosis research.

Chicago

Boles Jeremiah C, Williams Julie C, Hollingsworth Rachel M, Wang Jian-Guo, Glover Sam L, Owens A Phillip, Barcel David A, Kasthuri Raj S, Key Nigel S and Mackman Nigel. 20120522. Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity. : Thrombosis research.

Harvard

Boles J. C., Williams J. C., Hollingsworth R. M., Wang J., Glover S. L., Owens A. P., Barcel D. A., Kasthuri R. S., Key N. S. and Mackman N. (20120522). Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity. : Thrombosis research.

MLA

Boles Jeremiah C, Williams Julie C, Hollingsworth Rachel M, Wang Jian-Guo, Glover Sam L, Owens A Phillip, Barcel David A, Kasthuri Raj S, Key Nigel S and Mackman Nigel. Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity. : Thrombosis research. 20120522.